NIH-Backed Startup Amissa Launches AI Platform to Fix Menopause Care’s $24.8B Data Blind Spot

Adopted nationwide, Amissa is the first clinical intelligence platform for menopause—turning fragmented care into ...

Some Would Call It Ugly. To Me, It’s a Prized Possession—and a Dating Litmus Test.

I could lie and say I wear it to commemorate my grandmother, who passed away in 2023. And while there’s definitely some ...